Equitec Proprietary Markets Lowered Esperion Therapeutics Ne (ESPR) Position; Alliant Energy (LNT)’s Sentiment Is 1.18

January 23, 2018 - By Clifton Ray

Alliant Energy Corporation operates as a utility holding firm that provides regulated electricity and natural gas services to residential, commercial, industrial, and wholesale clients in the Midwest region of the United States. The company has market cap of $9.14 billion. It operates through three divisions: Electric, Gas, and Other. It has a 21.23 P/E ratio. The company, through its subsidiary, Interstate Power and Light Company , primarily generates and distributes electricity, and distributes and transports natural gas to retail clients in Iowa; sells electricity to wholesale clients in Minnesota, Illinois, and Iowa; and generates and distributes steam in Cedar Rapids, Iowa.

Equitec Proprietary Markets Llc decreased Esperion Therapeutics Inc Ne (ESPR) stake by 98.48% reported in 2017Q3 SEC filing. Equitec Proprietary Markets Llc sold 26,000 shares as Esperion Therapeutics Inc Ne (ESPR)’s stock rose 33.24%. The Equitec Proprietary Markets Llc holds 400 shares with $20,000 value, down from 26,400 last quarter. Esperion Therapeutics Inc Ne now has $2.04 billion valuation. The stock increased 0.95% or $0.73 during the last trading session, reaching $77.93. About 571,388 shares traded or 3.91% up from the average. Esperion Therapeutics, Inc. (NASDAQ:ESPR) has risen 133.75% since January 23, 2017 and is uptrending. It has outperformed by 117.05% the S&P500.

Since January 1, 0001, it had 0 insider buys, and 1 insider sale for $85,665 activity.

The stock increased 0.36% or $0.14 during the last trading session, reaching $39.55. About 1.69M shares traded or 15.00% up from the average. Alliant Energy Corporation (LNT) has risen 11.22% since January 23, 2017 and is uptrending. It has underperformed by 5.48% the S&P500.

Symons Capital Management Inc holds 5.04% of its portfolio in Alliant Energy Corporation for 479,692 shares. Crow Point Partners Llc owns 588,000 shares or 3.93% of their US portfolio. Moreover, United Fire Group Inc has 3.42% invested in the company for 244,400 shares. The Virginia-based Godsey & Gibb Associates has invested 2.32% in the stock. Duff & Phelps Investment Management Co, a Illinois-based fund reported 3.37 million shares.

Analysts await Alliant Energy Corporation (NYSE:LNT) to report earnings on February, 22. They expect $0.39 earnings per share, up 39.29% or $0.11 from last year’s $0.28 per share. LNT’s profit will be $90.17 million for 25.35 P/E if the $0.39 EPS becomes a reality. After $0.75 actual earnings per share reported by Alliant Energy Corporation for the previous quarter, Wall Street now forecasts -48.00% negative EPS growth.

Among 18 analysts covering Esperion Therapeutics (NASDAQ:ESPR), 11 have Buy rating, 0 Sell and 7 Hold. Therefore 61% are positive. Esperion Therapeutics had 53 analyst reports since July 28, 2015 according to SRatingsIntel. The company was maintained on Wednesday, June 29 by Lake Street. The company was maintained on Thursday, February 25 by Stifel Nicolaus. The stock has “Market Outperform” rating by JMP Securities on Wednesday, March 9. The stock of Esperion Therapeutics, Inc. (NASDAQ:ESPR) earned “Hold” rating by Citigroup on Monday, January 22. The rating was downgraded by Citigroup on Monday, November 14 to “Neutral”. On Wednesday, August 19 the stock rating was upgraded by Needham to “Strong Buy”. Needham maintained the shares of ESPR in report on Thursday, June 30 with “Buy” rating. As per Tuesday, September 29, the company rating was maintained by Chardan Capital Markets. Northland Capital maintained Esperion Therapeutics, Inc. (NASDAQ:ESPR) on Wednesday, November 22 with “Buy” rating. The stock has “Buy” rating by Northland Capital on Tuesday, October 3.

Investors sentiment increased to 1.67 in Q3 2017. Its up 0.45, from 1.22 in 2017Q2. It is positive, as 11 investors sold ESPR shares while 34 reduced holdings. 30 funds opened positions while 45 raised stakes. 22.73 million shares or 17.55% more from 19.33 million shares in 2017Q2 were reported. Credit Agricole S A has 157,900 shares. Sg Americas Securities Limited Liability Company owns 3,423 shares. Next Financial Group owns 61 shares for 0% of their portfolio. Art Advisors Llc invested in 0.08% or 30,560 shares. St Johns Invest Company Lc holds 0.01% of its portfolio in Esperion Therapeutics, Inc. (NASDAQ:ESPR) for 260 shares. Sabby Mngmt Ltd Limited Liability Company reported 83,357 shares. Quantitative Inv Mgmt Ltd Liability Co holds 123,600 shares. Tiaa Cref Management Ltd Liability Com reported 42,254 shares. 721 were reported by Quantbot Tech L P. First Mercantile Com reported 2,714 shares stake. Moreover, Millennium Mngmt Ltd Liability Corp has 0% invested in Esperion Therapeutics, Inc. (NASDAQ:ESPR) for 33,367 shares. Rothschild Asset, New York-based fund reported 22,425 shares. Trexquant Investment Ltd Partnership stated it has 0.21% of its portfolio in Esperion Therapeutics, Inc. (NASDAQ:ESPR). Moore Cap Mngmt Limited Partnership reported 0.04% of its portfolio in Esperion Therapeutics, Inc. (NASDAQ:ESPR). California State Teachers Retirement Systems reported 27,154 shares or 0% of all its holdings.

Equitec Proprietary Markets Llc increased Time Warner Inc (Put) (NYSE:TWX) stake by 37,100 shares to 65,600 valued at $6.72M in 2017Q3. It also upped Syngenta Ag (Put) (NYSE:SYT) stake by 80,400 shares and now owns 118,800 shares. Time Warner Inc (NYSE:TWX) was raised too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.